Researchers demonstrated the effectiveness of soft robotic apparel in averting Freezing of Gait (FoG) in Parkinson’s disease (PD) patients, showcasing significant improvements in mobility and gait quality.
GSK steps in for J&J’s license of Arrowhead’s hepatitis B drug, plans combo study with its own candidate
British drugmaker GSK plans to acquire an experimental hepatitis B drug from Johnson & Johnson and its developer Arrowhead Pharmaceuticals and then combine the siRNA